Krause K, Degener F, Altrichter S, Ardelean E, Kalogeromitros D, Magerl M, Metz M, Siebenhaar F, Weller K, Maurer M
Klinik für Dermatologie, Venerologie und Allergologie, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin.
Hautarzt. 2010 Sep;61(9):743-9. doi: 10.1007/s00105-010-1932-9.
The onset of wheals and/or angioedema following the exposure to cold may be associated with a number of different diseases. Most frequently this occurs in cold contact urticaria, a type of physical urticaria, which is characterized by a positive cold stimulation test. The clinical symptoms are based on cold-dependent mast cell activation with subsequent release of proinflammatory mediators. In cases of negative or atypical reaction to cold stimulation testing rare acquired atypical or familiar cold urticaria forms may be suspected. Strict avoidance of cold should be recommended as far as possible. As the underlying causes of cold contact urticaria are widely unknown, the symptomatic use of non-sedating antihistamines is the treatment of first choice. The very rare familiar cold auto-inflammatory syndrome (FCAS) is based on CIAS1/NLRP3 mutations and may be treated effectively by neutralization of pathogenic interleukin 1beta.
接触寒冷后出现风团和/或血管性水肿可能与多种不同疾病相关。最常见于冷接触性荨麻疹,这是一种物理性荨麻疹,其特征为冷刺激试验呈阳性。临床症状基于冷依赖性肥大细胞活化以及随后促炎介质的释放。对于冷刺激试验呈阴性或非典型反应的情况,可能怀疑为罕见的获得性非典型或家族性冷荨麻疹形式。应尽可能建议严格避免寒冷。由于冷接触性荨麻疹的潜在病因大多未知,对症使用非镇静性抗组胺药是首选治疗方法。非常罕见的家族性冷自身炎症综合征(FCAS)基于CIAS1/NLRP3突变,可通过中和致病性白细胞介素1β进行有效治疗。